Endo (NDOI) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Endo's Free Cash Flow for the three months ended in Dec. 2024 was $0 Mil. Endo's Revenue for the three months ended in Dec. 2024 was $0 Mil. Therefore, Endo's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Endo's current FCF Yield % is -37.06%.

The historical rank and industry rank for Endo's FCF Margin % or its related term are showing as below:

NDOI' s FCF Margin % Range Over the Past 10 Years
Min: -44.44 Med: 12.13 Max: 16.94
Current: -44.44

During the past 3 years, the highest FCF Margin % of Endo was 16.94%. The lowest was -44.44%. And the median was 12.13%.

NDOI's FCF Margin % is ranked worse than
87.46% of 981 companies
in the Drug Manufacturers industry
Industry Median: 0.86 vs NDOI: -44.44

Endo FCF Margin % Historical Data

The historical data trend for Endo's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo FCF Margin % Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

FCF Margin %

7.31

16.94

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial			24.33	19.08	-131.34	-	-

Competitive Comparison of Endo's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Endo's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Endo FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Endo's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	0	/	0
	=	%

Endo's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

Endo FCF Margin % Related Terms

Thank you for viewing the detailed overview of Endo's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.